Market overview
The global cardiovascular devices market is worth USD 83.8 bn in 2026 and is forecast to reach USD 165 bn by 2036, growing at a 7.0% CAGR. United States is the largest country market and Coronary and peripheral vascular is the largest by product segment.
| Scope | Devices for heart and vascular disease: stents, heart valves, pacemakers and defibrillators, electrophysiology catheters, heart pumps, vascular grafts and structural heart implants. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 78.0 bn |
| Value 2026 | USD 83.8 bn |
| Value 2036 | USD 165 bn |
| CAGR 2026-2036 | 7.0% |
| Volume 2026 | 23.5 million procedures |
| Volume 2036 | 44.0 million procedures |
| Average price 2026 | USD 3,563 per procedure |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Cardiovascular Devices market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 83.8 bn |
| 2027 | USD 89.7 bn |
| 2028 | USD 96.0 bn |
| 2029 | USD 103 bn |
| 2030 | USD 110 bn |
| 2031 | USD 118 bn |
| 2032 | USD 126 bn |
| 2033 | USD 135 bn |
| 2034 | USD 144 bn |
| 2035 | USD 154 bn |
| 2036 | USD 165 bn |
Cardiovascular Devices market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Cardiac rhythm management | 26.0% | 20.8% | USD 21.8 bn | 4.6% |
| Electrophysiology and ablation | 18.0% | 26.2% | USD 15.1 bn | 11.1% |
| Structural heart | 17.0% | 22.6% | USD 14.3 bn | 10.1% |
| Coronary and peripheral vascular | 32.0% | 23.3% | USD 26.8 bn | 3.6% |
| Heart failure and others | 7.0% | 7.1% | USD 5.9 bn | 7.1% |
By end use
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 78.0% | 75.3% | USD 65.4 bn | 6.6% |
| Ambulatory surgical centers | 15.0% | 18.2% | USD 12.6 bn | 9.1% |
| Cardiac centres and clinics | 7.0% | 6.4% | USD 5.9 bn | 6.1% |
By procedure
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Interventional | 46.0% | 46.0% | USD 38.6 bn | 7.0% |
| Surgical | 24.0% | 22.0% | USD 20.1 bn | 6.1% |
| Monitoring and diagnostic | 30.0% | 32.0% | USD 25.2 bn | 7.7% |
By condition
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Coronary artery disease | 34.0% | 32.0% | USD 28.5 bn | 6.3% |
| Heart rhythm disorders | 24.0% | 26.0% | USD 20.1 bn | 7.9% |
| Structural heart disease | 18.0% | 20.0% | USD 15.1 bn | 8.1% |
| Heart failure | 14.0% | 14.0% | USD 11.7 bn | 7.0% |
| Peripheral vascular | 10.0% | 8.0% | USD 8.4 bn | 4.6% |
By technology
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Implantables | 44.0% | 46.0% | USD 36.9 bn | 7.5% |
| Catheters | 26.0% | 25.0% | USD 21.8 bn | 6.6% |
| Imaging and monitors | 30.0% | 29.0% | USD 25.2 bn | 6.6% |
Top 25 countries for cardiovascular devices by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 84.5% of 2026 revenue and the 25 countries below together hold 95.5%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 36.9 bn | 44.0% | USD 71.4 bn | 6.8% |
| 2 | China | USD 7.5 bn | 9.0% | USD 17.6 bn | 8.9% |
| 3 | Germany | USD 5.9 bn | 7.0% | USD 10.9 bn | 6.4% |
| 4 | Japan | USD 5.0 bn | 6.0% | USD 8.4 bn | 5.3% |
| 5 | France | USD 3.4 bn | 4.0% | USD 6.3 bn | 6.5% |
| 6 | Italy | USD 2.9 bn | 3.5% | USD 5.4 bn | 6.4% |
| 7 | United Kingdom | USD 2.9 bn | 3.5% | USD 5.6 bn | 6.7% |
| 8 | Spain | USD 2.1 bn | 2.5% | USD 3.8 bn | 6.1% |
| 9 | India | USD 2.1 bn | 2.5% | USD 5.9 bn | 11.0% |
| 10 | Brazil | USD 2.1 bn | 2.5% | USD 4.5 bn | 7.8% |
| 11 | Switzerland | USD 1.6 bn | 1.9% | USD 3.0 bn | 6.7% |
| 12 | Netherlands | USD 1.3 bn | 1.5% | USD 2.5 bn | 6.8% |
| 13 | Australia | USD 1.3 bn | 1.5% | USD 2.4 bn | 6.8% |
| 14 | Belgium | USD 1.1 bn | 1.3% | USD 2.2 bn | 6.8% |
| 15 | Ireland | USD 805 mn | 1.0% | USD 1.5 bn | 6.7% |
| 16 | Sweden | USD 612 mn | 0.7% | USD 1.2 bn | 6.7% |
| 17 | Poland | USD 503 mn | 0.6% | USD 1.1 bn | 8.0% |
| 18 | Turkey | USD 495 mn | 0.6% | USD 1.1 bn | 8.0% |
| 19 | Mexico | USD 377 mn | 0.5% | USD 825 mn | 8.1% |
| 20 | Saudi Arabia | USD 293 mn | 0.3% | USD 627 mn | 7.9% |
| 21 | Austria | USD 243 mn | 0.3% | USD 462 mn | 6.6% |
| 22 | Denmark | USD 201 mn | 0.2% | USD 379 mn | 6.5% |
| 23 | Israel | USD 193 mn | 0.2% | USD 379 mn | 7.0% |
| 24 | Singapore | USD 151 mn | 0.2% | USD 330 mn | 8.1% |
| 25 | Canada | USD 134 mn | 0.2% | USD 264 mn | 7.0% |
| Rest of world | USD 3.8 bn | 4.5% | USD 6.9 bn | 6.2% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Medtronic
- Abbott
- Boston Scientific
- Edwards Lifesciences
- Johnson and Johnson MedTech
- Terumo
Group 2: Regional and specialist players
- Biotronik
- MicroPort
- B. Braun
- Teleflex
- LivaNova
- Biosensors
- W. L. Gore
- Cordis
- Penumbra
- Cook Medical
Group 3: Emerging and niche players
- Meril
- Lepu Medical
- Shockwave Medical
- Artivion
- CVRx
- Impulse Dynamics
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the cardiovascular devices market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.0% is calculated from the resulting values.
The market is divided by product, by end use, by procedure, by condition, by technology. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the cardiovascular devices market?
The global cardiovascular devices market is estimated at USD 78.0 bn in 2025 and USD 83.8 bn in 2026.
How fast will the cardiovascular devices market grow?
It is forecast to reach USD 165 bn by 2036, a compound annual growth rate of 7.0% from 2026, an increase of USD 81.1 bn.
Which country is the largest market for cardiovascular devices?
United States is the largest market by revenue at USD 36.9 bn in 2026, 44.0% of the global total. The three largest countries together hold 60.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 11.0% a year from 2026 to 2036.
Which cardiovascular devices segment is largest?
In the by product split, Coronary and peripheral vascular is the largest segment with 32.0% of 2026 revenue.
Who are the leading cardiovascular devices companies?
Global leaders include Medtronic, Abbott, Boston Scientific, Edwards Lifesciences.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- VaccinesUSD 80.6 bn · 7.0% CAGR
- ImmunotherapyUSD 77.7 bn · 8.5% CAGR
- Contract Research OrganizationUSD 91.8 bn · 8.0% CAGR
- Generic InjectableUSD 93.3 bn · 6.3% CAGR
- Diabetes DrugsUSD 97.5 bn · 5.0% CAGR
- Revenue Cycle ManagementUSD 68.8 bn · 11.0% CAGR
- TelemedicineUSD 103 bn · 13.0% CAGR
- Drug Delivery SystemsUSD 67.0 bn · 8.0% CAGR
← Carboxylate-Modified Magnetic Beads Cardiovascular Drug Discovery →